Series | # Pts | Local Control | Distant Metastases | Survival |
---|---|---|---|---|
MayoClinic(14) | 146 | 3-year: 90% | 3-year: 43% | MS: 44 mo |
5-year: 52% | ||||
MGH(15) | 42 | 5-year: 77% | Not Reported | Not Reported |
Madrid (16) | 115 | 3-year: 94% | 3-year: 21% | MS: Not Reached |
3-year: 74% | ||||
Heidelberg (17) | 210 | 5-year: 93% | Not Reported | 5-year: 69% |
Cleveland Clinic | 10 | 3-year: 100% | 3-year: 71% | MS: 49 mo |
5-year: 39% |